SCHEMBL203946

SCHEMBL203946

Cc1cc(Cl)cc(C)c1N

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 6/20 0.58
▸ ALDH1A1 P00352 5/20 0.58
▸ TSHR P16473 3/20 0.58
▸ TP53 P04637 2/20 0.58
▸ TDP1 Q9NUW8 2/20 0.58
▸ POLB P06746 1/20 0.48
▸ CD44 P16070 1/20 0.43
▸ CYP1A1 P04798 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ GAA P10253 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ RAPGEF4 Q8WZA2 2/20 0.38
▸ SCN4A P35499 2/20 0.38
▸ MAPK1 P28482 1/20 0.36
▸ CES1 P23141 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4006326 0.97 CYP3A4 (0.55) CYP3A4ALDH1A1TSHRTP53TDP1
SCHEMBL30462201 0.86 CD44 (0.44) CYP3A4ALDH1A1TSHRTP53TDP1
SCHEMBL203098 0.86 CD44 (0.44) CYP3A4ALDH1A1TSHRTP53TDP1
SCHEMBL1196837 0.86 CYP3A4 (0.52) CYP3A4ALDH1A1TSHRTP53TDP1
SCHEMBL31213263 0.86 CYP3A4 (0.52) CYP3A4ALDH1A1TSHRTP53TDP1
Hydrochloric Acid SCHEMBL17825746 0.84 CYP3A4 (0.50) CYP3A4ALDH1A1TSHRTP53TDP1
SCHEMBL8058631 0.82 CYP3A4 (0.40) CYP3A4ALDH1A1TSHRTP53TDP1
SCHEMBL2427550 0.82 CYP3A4 (0.40) CYP3A4ALDH1A1TSHRTP53TDP1
SCHEMBL12329568 0.82 CYP3A4 (0.40) CYP3A4ALDH1A1TSHRTP53TDP1
SCHEMBL19899595 0.82 ALDH1A1 (0.52) CYP3A4ALDH1A1TSHRTP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119039132-A Preparation method of 2- (4-chloro-2, 6-dimethylphenyl) acetic acid 浙江工业大学 2024-11-29 — — CN claimed
US-11111207-B2 One pot, one step process for the halogenation of aromatics using solid acid catalysts COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2021-09-07 — — US claimed
US-20190100487-A1 AN IMPROVED ONE POT, ONE STEP PROCESS FOR THE HALOGENATION OF AROMATICS USING SOLID ACID CATALYSTS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2019-04-04 — — US claimed
EP-1773768-B1 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS INC (US) 2018-08-22 — — EP claimed
WO-2017163262-A1 AN IMPROVED ONE POT, ONE STEP PROCESS FOR THE HALOGENATION OF AROMATICS USING SOLID ACID CATALYSTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-09-28 — — WO claimed
CN-101402731-A Polyphenylene sulfide copolymer containing aromatic heterocycle, preparation method, application and product thereof DEYANG KEJI NEW MATERIAL CO LT (CN) 2009-04-08 — — CN claimed
EP-1773768-A4 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS INC (US) 2008-08-06 — — EP claimed
EP-1773768-A2 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS Exelixis, Inc. (US) 2007-04-18 — — EP claimed
WO-2006012642-A2 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS, INC. (US) 2006-02-02 — — WO claimed
CN-122036596-A N- (2 ',6' -xylyl) -2-piperidine carboxamide derivative and application thereof 中国药科大学 2026-05-15 — — CN disclosed
US-20260116859-A1 Charged Ion Channel Blockers and Methods for Use NOCION THERAPEUTICS INC (US) 2026-04-30 — — US disclosed
EP-4130195-B1 COMPOSITION AND LIGHT-EMITTING ELEMENT CONTAINING SAME SUMITOMO CHEMICAL CO (JP) 2025-09-03 — — EP disclosed
EP-4608818-A1 HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING Boehringer Ingelheim International GmbH (DE) 2025-09-03 — — EP disclosed
WO-2025120516-A1 COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2025-06-12 — — WO disclosed
US-4150154-A GASTROINTESTINAL ANTISPASMODICS WILLIAM H. RORER, INC. (US) 1979-04-17 — — US disclosed
US-4147804-A ANTIARRHYTHMIA AGENTS WILLIAM H. RORER, INC. (US) 1979-04-03 — — US disclosed
US-4141718-A ANTIGROWTH AGENTS FOR PLANTS CIBA-GEIGY CORPORATION (US) 1979-02-27 — — US disclosed
US-4060635-A Amidinoureas for treating diarrhea WILLIAM H. RORER, INC. (US) 1977-11-29 — — US disclosed
US-3983174-A HERBICIDES VELSICOL CHEMICAL CORPORATION (US) 1976-09-28 — — US disclosed
US-3954997-A MITICIDES, INSECTICIDES THE UPJOHN COMPANY (US) 1976-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190100487-A1 AN IMPROVED ONE POT, ONE STEP PROCESS FOR THE HALOGENATION OF AROMATICS USING SOLID ACID CATALYSTS TYR, PAH, ABL1 CYP3A4 33/4885ALDH1A1 232/4885TSHR 253/4885
US-11111207-B2 One pot, one step process for the halogenation of aromatics using solid acid catalysts TYR, PAH, ABL1 CYP3A4 50/4885ALDH1A1 147/4885TSHR 202/4885
US-20260116859-A1 Charged Ion Channel Blockers and Methods for Use OPRL1, TRPV1, SCN2B CYP3A4 2398/4885ALDH1A1 3216/4885TSHR 496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback